MedTrace Logo

Enhancing the Secondary Prevention of Coronary Artery Disease

NCT00175240 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2015-07-28

No results posted yet for this study

Summary

People with coronary artery disease can reduce their chance of having a heart attack by making healthy lifestyle choices (diet, exercise, quitting smoking,etc.). There are also many medications that have been proven to reduce the risk of heart attacks and may even help people live longer. This study will look at different ways of improving the use of these beneficial medications to enhance the quality of care for people with this condition.

Conditions

  • Coronary Disease
  • Ischemic Heart Disease

Interventions

BEHAVIORAL

Evidence summaries endorsed by local opinion leaders

Sponsors & Collaborators

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Alberta Heritage Foundation for Medical Research

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • University of Alberta

    lead OTHER

Principal Investigators

  • Finlay McAlister, MD,MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2011-08-31
Completion
2015-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00175240 on ClinicalTrials.gov